We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -6.10328638498 | 2.13 | 2.2399 | 2.015 | 1927 | 2.11631755 | CS |
4 | -0.96 | -32.4324324324 | 2.96 | 3.1002 | 2.015 | 5487 | 2.28445753 | CS |
12 | -0.41 | -17.0124481328 | 2.41 | 3.3 | 2.015 | 5023 | 2.62636199 | CS |
26 | -0.33 | -14.1630901288 | 2.33 | 3.3 | 1.87 | 7272 | 2.53145324 | CS |
52 | -0.75 | -27.2727272727 | 2.75 | 4.05 | 1.62 | 9843 | 2.49531399 | CS |
156 | -5.35 | -72.7891156463 | 7.35 | 8.6988 | 1.62 | 8258 | 3.83977637 | CS |
260 | -5.38 | -72.8997289973 | 7.38 | 9.33 | 1.62 | 10221 | 4.58267933 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions